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POSITION STATEMENT ISSUED
ON HSCT FOR PEDIATRIC AML
For many children with acute my-
eloid leukemia (AML), transplantation of
blood or marrow stem cells, combined
with chemotherapy, offers improved
survival compared to chemotherapy
alone. Allogeneic transplantation using
blood or marrow stem cells from do-
nors related to the patient offers better
survival than autologous transplants.
These are among the guidelines in-
cluded in an ASBMT position state-
ment on stem cell therapy for pediat-
ric AML.
The recommendations are based
on an evidence-based review of the
scientific literature on the use of he-
matopoietic stem cell transplantation
(HSCT) in children with AML, pub-
lished in the January 2007 issue of
Biology of Blood and Marrow Trans-
plantation. Developed in collabora-
tion with the National Marrow Donor
Program (NMDP), the review was
conducted by a panel of indepen-
dent experts in transplantation and
other treatments for leukemia.
For patients with certain forms of
cancer, such as leukemia, and specific
genetic diseases or blood disorders,
HSCT can improve survival and, in
many cases, cure the disease, accord-
ing to the evidence-based review and
the position statement. Among the
specific recommendations are:
● Allogeneic HSCT after chemother-
apy offers superior overall survival
and leukemia-free survival when
compared to chemotherapy alone
for patients in first complete remis-
sion.
● Autologous HSCT or chemother-
apy alone given in the first com-
plete disease remission are equiv-
alent in outcomes, but a lack of
data on quality of life, secondary
cancers and other late effects of
treatment prevent a recommenda-
tion of one treatment over an-
other.
● HSCT is recommended over che-
motherapy alone in second com-
plete remission when a suitably
matched related donor is avail-
able.
● Hematopoietic stem cells donated
by a matched related or unrelated
donor are superior in outcome to
stem cells harvested through au-
tologous transplantation in first
and second complete remission.
WEB SITE HELPS PHYSICIANS
RESPOND TO RADIATION EVENTS
A new Web site to help physicians
and other health personnel respond
to a radiation incident has been intro-
duced by the U.S. Department of
Health and Human Services. ASBMT
and the National Marrow Donor Pro-
gram (NMDP) provided substantial in-
put, particularly with diagnostic and
patient management guidelines.
Entitled the Radiation Event Medi-
cal Management (REMM) Web site,
the online presentation includes
downloadable easy-to-follow proce-
dures for diagnosis and management
of radiation contamination and expo-
sure, guidance for the use of radia-
tion medical countermeasures, and a
variety of other features related to
medical response. The Web address is
http://remm.nlm.gov.
“The REMM tool kit is part of our
effort to improve public health emer-
gency preparedness and response,”
HHS Secretary Mike Leavitt said in an-
nouncing the Web site. “It reflects the
department’s commitment to help in-
still a spirit of preparedness through-
out our nation.”
The Web site materials provide
guidance on diagnosis and treatment
by describing:
● types of radiation emergencies
health professionals may face
● initial medical actions at the inci-
dent site or medical facility
● key steps in patient care
“The information is presented in a
format that can quickly and effi-
ciently orient and guide health care
providers during a mass casualty ra-
diation event such as a nuclear ex-
plosion, reactor accident, terrorist
radiological dispersal or a nuclear
fuel transportation accident,” said
Dr. Nelson Chao, ASBMT past presi-
dent who led the society’s work on
the tool kit.
“The guidelines and materials are
designed not just for emergency re-
sponders such as police, rescue and
emergency room personnel, but also
for physicians and other health pro-
fessionals to whom patients may be
referred,” he said.
Dr. Daniel Weisdorf, NMDP scien-
tific director, added that “in addition
to having online access, federal, state
and local medical response teams will
be able to download REMM informa-
tion onto laptop computers for quick
access when deployed to a radiation
incident or for training sessions. Users
can also register for automatic e-mail
updates whenever information is
changed or added to the REMM Web
site.”
He said that future plans include
formatting the REMM material for use
on Personal Digital Assistant (PDA) de-
vices, additional multimedia graphics
and more topic areas, such as fol-
low-up patient care of radiation’s
chronic effects.
In addition to the ASBMT and
NMDP representatives, the Web site
development team included person-
nel from the HHS Office of the Assis-
tant Secretary for Preparedness and
Response, the NIH National Cancer
Institute and the National Library of
Medicine, and the Centers for Disease
Control and Prevention.
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